Repository logo
  • English
  • 中文
Log In
Have you forgotten your password?
  1. Home
  2. College of Medicine / 醫學院
  3. School of Medicine / 醫學系
  4. BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer
 
  • Details

BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer

Journal
Medical Oncology
Journal Volume
33
Journal Issue
5
Date Issued
2016
Author(s)
KUO-HSING CHEN  
Lin Y.-L.
JAU-YU LIAU  
JIA-HUEI TSAI  
LI-HUI TSENG  
LIANG-IN LIN  
JIN-TUNG LIANG  
BEEN-REN LIN  
JI-SHIANG HUNG  
YIH-LEONG CHANG  
KUN-HUEI YEH  
ANN-LII CHENG  
DOI
10.1007/s12032-016-0756-6
URI
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84962439814&doi=10.1007%2fs12032-016-0756-6&partnerID=40&md5=27e2efae3b2810f289d2118933016c42
https://scholars.lib.ntu.edu.tw/handle/123456789/462201
Abstract
The prognostic implication of BRAF mutant colorectal cancer remains paradoxical. Records of BRAF mutant and wild-type colorectal cancer patients at all stages were reviewed. Clinicopathologic features, including microsatellite instability, CpG islands methylator phenotype, and overall survival, of these patients were analyzed. Between 2005 and 2013, 428 colorectal cancer patients were enrolled in this study. The overall survival between BRAF mutant and wild-type patients with early-stage (stages I and II) colorectal cancer differed nonsignificantly (P?=?0.99). By contrast, in late-stage (stages III and IV) patients, the median overall survival of BRAF mutant patients (N?=?25) was significantly poorer than that of BRAF wild-type (N?=?207) patients (BRAF mutant: 21.3?months (95?% confidence interval [CI] 7.1–35.5); BRAF wild-type: 53.5?months (95?% CI 37.5–69.5), P?
SDGs

[SDGs]SDG3

Other Subjects
B Raf kinase; bevacizumab; cetuximab; fluorouracil; folinic acid; irinotecan; oxaliplatin; B Raf kinase; BRAF protein, human; adjuvant therapy; adult; Article; cancer adjuvant therapy; cancer combination chemotherapy; cancer patient; cancer prognosis; cancer staging; cancer surgery; cancer survival; chemoembolization; clinical feature; colorectal cancer; controlled study; CpG island; female; genetic association; human; local therapy; major clinical study; male; medical record review; metastasis resection; methylator phenotype; microsatellite instability; monotherapy; multimodality cancer therapy; mutant; mutational analysis; overall survival; phenotype; priority journal; radiofrequency ablation; retrospective study; systemic therapy; tumor ablation; wild type; aged; colorectal tumor; DNA methylation; genetics; Kaplan Meier method; middle aged; mortality; multivariate analysis; mutation; pathology; prognosis; Aged; Colorectal Neoplasms; CpG Islands; DNA Methylation; Female; Humans; Kaplan-Meier Estimate; Male; Microsatellite Instability; Middle Aged; Multivariate Analysis; Mutation; Prognosis; Proto-Oncogene Proteins B-raf
Publisher
Humana Press Inc.
Type
journal article

臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

  • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔,可使用Open policy finder網站查詢,以確認出版單位之版權政策。
    Please use Open policy finder to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
  • 網站簡介 (Quickstart Guide)
  • 使用手冊 (Instruction Manual)
  • 線上預約服務 (Booking Service)
  • 方案一:臺灣大學計算機中心帳號登入
    (With C&INC Email Account)
  • 方案二:ORCID帳號登入 (With ORCID)
  • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
  • 方案二:自行建檔 (Default mode Submission)
  • 方案三:學科館員協助匯入 (Email worklist to subject librarians)

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science